ERBB2 and breast carcinoma: Based on gene expression profiles and the presence of specific biomarkers, breast cancer can be classified into the following major molecular subtypes: Luminal A, Luminal B (HER2-negative), Luminal B (HER2-positive), HER2-positive, and basal-like tumor breast cancers (mainly triple-negative, TNBC).